News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure would have liked to have seen the supposed suspect press release(s) that the SEC claims were suspect. I have Googled, Yahoo'd, and EDGAR'd myself to death trying to find a single word that Arcaro would have put out to have caused the suspension......and even though the suspension ended as of the 22nd, it is no longer trading. Can't even find it on the greys..........
Thanks a lot, SEC. Another stellar performance of focusing on "scammers"..........while you allow the likes of Raven Moon to continue............
Jul 8, 2008
Pink OTC Markets News Service
Las Vegas, Nevada—
UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934 RELEASE NO. 58116 / July 8, 2008
SECURITIES AND EXCHANGE COMMISSION TEMPORARILY SUSPENDS TRADING IN VMT SCIENTIFIC, INC.
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of trading of the securities of VMT Scientific, Inc. ("VMT"), of Las Vegas, Nevada at 9:30 a.m. EDT on July 8, 2008 and terminating at 11:59 p.m. EDT on July 21, 2008.
The Commission temporarily suspended trading in the securities of VMT because of questions that have been raised regarding the accuracy of assertions in press releases concerning, among other things: (1) the legal status of VMT Scientific; (2) VMT Scientific's business combinations; (3) VMT Scientific's current financial condition; and
(4) VMT Scientific's assets.
Don't Drink It, just Sip It....then move on to the next play
|
Followers
|
4
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
236
|
|
Created
|
11/28/05
|
Type
|
Free
|
| Moderators | |||
VMTF.PK http://www.vmtf.org/
VMT Scientific, Inc. (OTC: VMTF)
Website: www.vmtf.com
Outstanding Shares: 180,650,000
Estimated Float: 5,000,000
State Of Incorporation: NV
Country Of Incorporation: USA
Company Officers: Eugene F. Koppenhaver, Sole Officer, Dir.
SEC Reporting Status: De-Registered
CIK: 0001069402
Transfer Agent
Standard Transfer & Trust Company, Inc.
2980 South Rainbow Blvd.
Suite 220H
Las Vegas, NV 98146
Industry: Health / Biotechnology
VMT Scientific Inc. Announces Unilateral Development
Monday November 28, 6:01 am ET
LAS VEGAS, Nov. 28 /PRNewswire-FirstCall/ -- VMT Scientific Inc. (OTC: VMTF - News) announces that's its globally patented breakthrough technology known as the VasCir (TM) system has now begun development of it's hand, finger and limb units, as well as the feet. After fielding calls from desperate individuals facing amputations, their Doctors, requesting to be part of the trials as to help speed testing and Medical Centers worldwide. VMT Scientific Inc has moved its scheduled monolithic development into a unilateral phase, where all products will be developed along the same lines. It's a FACT that in 2003, it was estimated that over one half billion people worldwide suffer from some form of Diabetic or Pre-Diabetic condition, that will effect the normal blood flow to their extremities and compromise their health. Out of that half billion people, approx 40% of those will lead to amputations.
The VasCir (TM) System is predicted to reduce the number of PVD related amputations by 50% or more. VMT Scientific Inc's CTO states that there is no known technology that can establish blood flow to the extremities the same way the VasCir (TM) system can. Documented preliminary tests indicated that as much as a 300% increase in arterial blood flow to the treated limb in as little as 15 minutes. This life and limb saving arterial blood carries with it rich oxygen and nutrients that are necessary for proper limb health.
The World's demand for the VasCir (TM) system is staggering! Based on USA estimates, every 8 minutes an individual's foot is amputated and a staggering 2 million toes and fingers are amputated annually due to the effects of PVD!
The potential market for VMT Scientific Inc's patented technology is in the millions of units sold annually. The VasCir (TM) system goal is to earn FDA approval and to qualify as a Medicare reimbursable. VMT Scientific Inc. is poised for a healthy financial future as well as saving lives and limbs. If these projected estimates hold true, everybody wins, the patients, the Doctors, and the Stockholders.
Please visit VMT Scientific, Inc.'s Web site for more information: http://www.vmtf.org
This Press Release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward- looking statements. Factors that may cause such a difference include risks related to VMT Scientific Inc.'s limited operating history, risks associated with completing development and obtaining FDA medical approvals, successful patent protection and prosecution, successful sale of licensed technology nationally or internationally. Technology will not meet with market acceptance, the risk of future warranty and product liability claims, the uncertainty of VMT Scientifics' future access to capital to sustain operations, achieve profitability, to secure and maintain relationships with suppliers, manufacturers and other third parties, reliance on key employees, and dependence on intellectual property and or continue as a going concern. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations.
Source: VMT Scientific Inc.
